Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

81. Fosfomycin (Fomicyt) - for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinary tract infections; nosocomial lower respiratory tract infections; bacterial meningitis; and bacteraemia

Fosfomycin (Fomicyt) - for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinary tract infections; nosocomial lower respiratory tract infections; bacterial meningitis; and bacteraemia Final Appraisal Recommendation Advice No: 3015 – October 2015 Fosfomycin (Fomicyt ® ) 40 mg/ml powder for solution for infusion Limited submission by Nordic Pharma UK Ltd Additional note(s): ? Fosfomycin (Fomicyt ® ) is appropriate (...) within NHS Wales for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinary tract infections; nosocomial lower respiratory tract infections; bacterial meningitis; and bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Fosfomycin (Fomicyt ® ) should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended

2015 All Wales Medicines Strategy Group

82. Interventions for preventing recurrent urinary tract infection during pregnancy. Full Text available with Trip Pro

Interventions for preventing recurrent urinary tract infection during pregnancy. Recurrent urinary tract infections (RUTI) are common in women who are pregnant and may cause serious adverse pregnancy outcomes for both mother and child including preterm birth and small-for-gestational-age babies. Interventions used to prevent RUTI in women who are pregnant can be pharmacological (antibiotics) or non-pharmacological (cranberry products, acupuncture, probiotics and behavioural modifications). So

2015 Cochrane

83. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). (Abstract)

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Treatment of complicated urinary-tract infections is challenging due to rising antimicrobial resistance. We assessed the efficacy and safety of ceftolozane-tazobactam, a novel antibacterial with Gram-negative activity, in the treatment of patients with complicated lower-urinary-tract infections (...) or pyelonephritis.ASPECT-cUTI was a randomised, double-blind, double-dummy, non-inferiority trial done in 209 centres in 25 countries. Between July, 2011, and September, 2013, hospital inpatients aged 18 years or older who had pyuria and a diagnosis of a complicated lower-urinary-tract infection or pyelonephritis were randomly assigned in a 1:1 ratio to receive intravenous 1·5 g ceftolozane-tazobactam every 8 h or intravenous high-dose (750 mg) levofloxacin once daily for 7 days. The randomisation schedule

2015 Lancet Controlled trial quality: predicted high

84. Prophylactic antibiotics for children with recurrent urinary tract infections

Prophylactic antibiotics for children with recurrent urinary tract infections Prophylactic antibiotics for urinary tract infections are no longer routinely recommended. A large number of children must be given prophylaxis to prevent one infection and antibiotic resistance is a major concern when treating community-acquired urinary tract infections. The results of three recent significant studies are examined, with focus on the efficacy of prophylaxis, and recommendations are made. Key Words

2015 Canadian Paediatric Society

85. Nitrofurantoin for the Treatment of Urinary Tract Infections in Elderly Males

Nitrofurantoin for the Treatment of Urinary Tract Infections in Elderly Males Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should (...) Infections in Elderly Males: Safety DATE: 3 February 2015 RESEARCH QUESTION What is the clinical evidence regarding the safety of nitrofurantoin in elderly males with urinary tract infections? KEY FINDINGS No literature was identified regarding the safety of nitrofurantoin for the treatment of urinary tract infections in elderly males. References of potential interest are provided in the appendix. METHODS A limited literature search was conducted on key resources including PubMed, The Cochrane Library

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

86. Treatment of Urinary Tract Infections in the Elderly

]. Available from: http://www.topalbertadoctors.org/cpgs/?sid=15&cpg_cats=66&cpg_info=41 See: Recommendations, page 1. 5. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clin Infect Dis [Internet]. 2010 [cited 2015 Feb 2];50(5): 625-663. Available from: http://cid.oxfordjournals.org/content (...) Treatment of Urinary Tract Infections in the Elderly Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid responses should be considered along

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

87. Development of Antibiotic Resistance to Norfloxacin in the Treatment of Urinary Tract Infections

Development of Antibiotic Resistance to Norfloxacin in the Treatment of Urinary Tract Infections Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid (...) Resistance to Norfloxacin in the Treatment of Urinary Tract Infections: Clinical Evidence DATE: 5 February 2015 RESEARCH QUESTION What is the clinical evidence on the development of antibiotic resistance to norfloxacin in the treatment of urinary tract infections (UTIs)? KEY FINDINGS One non-randomized study was identified regarding the development of antibiotic resistance to norfloxacin in the treatment of urinary tract infections. METHODS A limited literature search was conducted on key resources

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

88. Newborn Male Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer

Newborn Male Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within (...) Circumcision for the Prevention of Sexually Transmitted Infections, Urinary Tract Infections, and Cancer: Clinical Effectiveness and Guidelines DATE: 6 February 2015 RESEARCH QUESTIONS 1. What is the clinical effectiveness of newborn male circumcision for the prevention of sexually transmitted infections (STIs), urinary tract infections (UTIs), and cancer? 2. What are the evidence-based guidelines regarding the medical indications for newborn male circumcisions? KEY FINDINGS Seven systematic reviews and 16

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

89. Randomised controlled trial: Cranberry capsules (2 taken twice daily for an average 38?days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation

Randomised controlled trial: Cranberry capsules (2 taken twice daily for an average 38?days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation Cranberry capsules (2 taken twice daily for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation | BMJ Evidence-Based Medicine We use cookies (...) Username * Password * your user name or password? You are here Cranberry capsules (2 taken twice daily for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation Article Text Therapeutics/Prevention Randomised controlled trial Cranberry capsules (2 taken twice daily for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological

2015 Evidence-Based Medicine

90. Avycaz (ceftazidime-avibactam) - To treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no a

Avycaz (ceftazidime-avibactam) - To treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no a Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - AVYCAZ (ceftazidime-avibactam) Injection Company: Forest Research Institute, Inc. Application

2015 FDA - Drug Approval Package

91. Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection

Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection Mitchell MD, O'Donnell JA, Pegues DA, Umscheid CA Record Status This is a bibliographic record (...) of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Mitchell MD, O'Donnell JA, Pegues DA, Umscheid CA. Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection. Philadelphia: Center for Evidence-based Practice (CEP). 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Humans; Urinalysis; Urinary Catheters; Urinary Tract

2014 Health Technology Assessment (HTA) Database.

92. Urinary tract infection in infants and children: Diagnosis and management

Urinary tract infection in infants and children: Diagnosis and management Recent studies have resulted in major changes in the management of urinary tract infections (UTIs) in children. The present statement focuses on the diagnosis and management of infants and children >2 months of age with an acute UTI and no known underlying urinary tract pathology or risk factors for a neurogenic bladder. UTI should be ruled out in preverbal children with unexplained fever and in older children (...) with symptoms suggestive of UTI (dysuria, urinary frequency, hematuria, abdominal pain, back pain or new daytime incontinence). A midstream urine sample should be collected for urinalysis and culture in toilet-trained children; others should have urine collected by catheter or by suprapubic aspirate. UTI is unlikely if the urinalysis is completely normal. A bagged urine sample may be used for urinalysis but should not be used for urine culture. Antibiotic treatment for seven to 10 days is recommended

2014 Canadian Paediatric Society

93. Monitoring in vitro antibacterial efficacy of 26 Indian spices against multidrug resistant urinary tract infecting bacteria Full Text available with Trip Pro

Monitoring in vitro antibacterial efficacy of 26 Indian spices against multidrug resistant urinary tract infecting bacteria To screen methanolic extracts of 26 commonly used Indian spices against nine species of uropathogenic bacteria (Enterococcus faecalis, Staphylococcus aureus, Acinetobacter baumannii, Citrobacter freundii, Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa), isolated from clinical samples of a tertiary care

2014 Integrative medicine research

94. Urinary Tract Infections in Older Women Full Text available with Trip Pro

Urinary Tract Infections in Older Women 24570259 2014 03 03 2016 10 25 1538-3598 311 8 2014 Feb 26 JAMA JAMA JAMA patient page. Urinary tract infections in older women. 874 10.1001/jama.2014.1152 Mody Lona L Juthani-Mehta Manisha M eng R01 AG032298 AG NIA NIH HHS United States R01 AG041780 AG NIA NIH HHS United States Patient Education Handout United States JAMA 7501160 0098-7484 AIM IM Aged Female Humans Urinary Tract Infections complications diagnosis drug therapy etiology prevention

2014 JAMA

95. Zerbaxa (ceftolozane/tazobactam) - To treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI)

Zerbaxa (ceftolozane/tazobactam) - To treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI) Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - ZERBAXA (ceftolozane/tazobactam) Injection Company: Cubist Pharmaceuticals, Inc. Application No.: 206829 Approval Date: 12/19/2014 Persons with disabilities having problems accessing the PDF files below

2014 FDA - Drug Approval Package

96. Urinary Tract Infection in Children - Diagnosis

bacteriuria. British Medical Journal Clinical Research Ed. 1982; 285: 1307-10. 15. Coulthard MG, Nelson A, Smith T et al. Point-of-care diagnostic tests for childhood urinary-tract infection: phase-contrast microscopy for bacteria, stick testing, and counting white blood cells. Journal of Clinical Pathology. 2010; 63: 823-9. 16. Williams GJ, Macaskill P, Chan SF et al. Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. The Lancet Infectious (...) Urinary Tract Infection in Children - Diagnosis ________________________________________________________________________________________________________________________ Diagnosis and Treatment of UTI in Children: Diagnosis September 2014 Page 1 of 23 DIAGNOSIS AND TREATMENT OF URINARY TRACT INFECTION IN CHILDREN: DIAGNOSIS Date written: September 2014 Author: Joshua Kausman, Margie Danchin Scope of Guidelines Specialist assessment and management is required for children who are considered

2014 KHA-CARI Guidelines

97. Urinary Tract Infection in Children - Management & investigation of recurrent UTI/VUR

Urinary Tract Infection in Children - Management & investigation of recurrent UTI/VUR ________________________________________________________________________________________________________________________ Diagnosis and Treatment of UTI in Children: Long-term Management September 2014 Page 1 of 17 DIAGNOSIS AND TREATMENT OF URINARY TRACT INFECTION IN CHILDREN: LONG TERM MANAGEMENT – RECURRENT URINARY TRACT INFECTION AND VESICOURETIC REFLUX Date written: September 2014 Author: Gabrielle (...) for children after a first urinary tract infection (UTI). (1A) b. We suggest that antibiotic prophylaxis be considered in young infants with a severe index UTI and for children with recurrent UTI and/or Grades III-V vesicoureteric reflux (VUR). (2B) Surgical interventions for recurrent UTI c. We do not recommend routine circumcision for boys after a first UTI. (1B) d. We suggest that circumcision be considered for boys with recurrent UTI or high grade VUR. (2C) e. We do not recommend surgical interventions

2014 KHA-CARI Guidelines

98. Urinary Tract Infection in Children - Radiological investigation following UTI

Urinary Tract Infection in Children - Radiological investigation following UTI ________________________________________________________________________________________________________________________ Diagnosis and Treatment of UTI in Children: Radiological Investigation September 2014 Page 1 of 17 DIAGNOSIS AND TREATMENT OF URINARY TRACT INFECTION IN CHILDREN: RADIOLOGICAL INVESTIGATION Date written: September 2014 Author: Michael Ditchfield, Sean Kennedy, Gabrielle Williams Scope of Guidelines (...) Specialist assessment and management is required for children who are considered at high risk of serious illness (underlying structural urinary tract abnormalities or neurogenic bladder or kidney transplant recipients). These children are beyond the scope of these guidelines and it is important that they are excluded from the recommendations detailed below. GUIDELINES a. We do not recommend routine renal tract imaging following a first urinary tract infection (UTI) except in the circumstances described

2014 KHA-CARI Guidelines

99. Diagnosis and Treatment of Urinary Tract Infection in Children

Diagnosis and Treatment of Urinary Tract Infection in Children KHA-CARI SUMMARY GUIDELINE – URINARY TRACT INFECTION IN CHILDREN. SEP 2014. Page | 1 This article is protected by copyright. All rights reserved. KHA-CARI Guideline Guideline title: Diagnosis and Treatment of Urinary Tract Infection in Children 1 Guideline authors: Steven McTaggart 1 , Margie Danchin 2,3 , Michael Ditchfield 4 , Ian Hewitt 5 , Joshua Kausman 6,7 , Sean Kennedy 8,9 , Peter Trnka 1,10 , Gabrielle Williams 11 . Running (...) Title: Urinary Tract Infection in Children Corresponding author: Steven McTaggart. Institution details E: Steven.McTaggart@health.qld.gov.au Tel: +63 7 3636 9219 Fax: +63 7 3636 1704 1 Child & Adolescent Renal Service, Royal Children's and Mater Children's Hospitals, University of Queensland, Brisbane, Australia. 2 Department of General Medicine, The Royal Children’s Hospital, Melbourne, Australia 3 Vaccine and Immunisation Research Group and Rotavirus Research Group, Murdoch Childrens Research

2014 KHA-CARI Guidelines

100. Urinary Tract Infection in Children - Acute management

Urinary Tract Infection in Children - Acute management ________________________________________________________________________________________________________________________ Diagnosis and Treatment of UTI in Children: Acute Management September 2014 Page 1 of 13 DIAGNOSIS AND TREATMENT OF URINARY TRACT INFECTION IN CHILDREN: ACUTE MANAGEMENT Date written: September 2014 Author: Peter Trnka, Steven McTaggart Scope of Guidelines Specialist assessment and management is required for children who (...) are considered at high risk of serious illness (underlying structural urinary tract abnormalities or neurogenic bladder or kidney transplant recipients). These children are beyond the scope of these guidelines and it is important that they are excluded from the recommendations detailed below. GUIDELINES General a. We recommend starting treatment for presumed urinary tract infection (UTI) in children who have clinical symptoms suggestive of UTI and who have positive leukocyte esterase or nitrite on urinary

2014 KHA-CARI Guidelines